Let it come. We have a unique situation. How many high trig patients are out there actively taking IPE for pancreatitis risk reduction? Anyone? This is a treble mouse trap. Just gonna take two more years than I wanted it.
NS From my interpretation of a poor translation: it sounds like they are using a new process to produce the 300 tons. Both generics will have to individually submit samples from three batches for FDA approval before it is allowed to be sold. It appears that could take a year and possibly more (production will be ready in early 2022 but the timeline on FDA approval seems uncertain). They seem to predict an increase in volume and margin in 2022 but I don’t think they are counting on the 300 tons until the end of the year. They sound pretty confident they can sell as much as they can produce. Their only concerns appear to be API supply and production capacity.
News 
Market Data 
Discover 
